• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发用于分子成像的磁共振探针。

Developing MR probes for molecular imaging.

作者信息

McMahon Michael T, Chan Kannie W Y

机构信息

F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA; The Russell H. Morgan Department of Radiology and Radiological Sciences, Division of MR Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA; The Russell H. Morgan Department of Radiology and Radiological Sciences, Division of MR Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Adv Cancer Res. 2014;124:297-327. doi: 10.1016/B978-0-12-411638-2.00009-4.

DOI:10.1016/B978-0-12-411638-2.00009-4
PMID:25287693
Abstract

Molecular imaging plays an important role in the era of personalized medicine, especially with recent advances in magnetic resonance (MR) probes. While the first generation of these probes focused on maximizing contrast enhancement, a second generation of probes has been developed to improve the accumulation within specific tissues or pathologies, and the newest generation of agents is also designed to report on changes in physiological status and has been termed "smart" agents. This represents a paradigm switch from the previously commercialized gadolinium and iron oxide probes to probes with new capabilities, and leads to new challenges as scanner hardware needs to be adapted for detecting these probes. In this chapter, we highlight the unique features for all five different categories of MR probes, including the emerging chemical exchange saturation transfer, (19)F, and hyperpolarized probes, and describe the key physical properties and features motivating their design. As part of this comparison, the strengths and weaknesses of each category are discussed.

摘要

分子成像在个性化医疗时代发挥着重要作用,尤其是随着磁共振(MR)探针的最新进展。第一代这类探针专注于最大化对比增强,而第二代探针已被开发出来以改善在特定组织或病变中的积聚,并且最新一代的试剂还被设计用于报告生理状态的变化,被称为“智能”试剂。这代表了从先前商业化的钆和氧化铁探针到具有新功能的探针的范式转变,并带来了新的挑战,因为扫描仪硬件需要进行调整以检测这些探针。在本章中,我们突出了所有五类不同MR探针的独特特性,包括新兴的化学交换饱和转移、(19)F和超极化探针,并描述了推动其设计的关键物理性质和特征。作为这种比较的一部分,还讨论了每一类的优缺点。

相似文献

1
Developing MR probes for molecular imaging.开发用于分子成像的磁共振探针。
Adv Cancer Res. 2014;124:297-327. doi: 10.1016/B978-0-12-411638-2.00009-4.
2
Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.磁共振化学交换饱和传递成像与纳米技术。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Jul-Aug;4(4):389-98. doi: 10.1002/wnan.1167. Epub 2012 Mar 15.
3
Molecular imaging with targeted contrast agents.使用靶向造影剂的分子成像。
Top Magn Reson Imaging. 2009 Aug;20(4):247-59. doi: 10.1097/RMR.0b013e3181ea28b1.
4
Bimodal magnetic-fluorescent probes for bioimaging.双模磁荧光探针用于生物成像。
Microsc Res Tech. 2011 Jul;74(7):563-76. doi: 10.1002/jemt.20912. Epub 2010 Aug 23.
5
An introduction to functional and molecular imaging with MRI.磁共振功能与分子成像简介。
Clin Radiol. 2010 Jul;65(7):557-66. doi: 10.1016/j.crad.2010.04.006.
6
Cellular and Molecular Imaging Using Chemical Exchange Saturation Transfer.利用化学交换饱和转移的细胞与分子成像
Top Magn Reson Imaging. 2016 Oct;25(5):197-204. doi: 10.1097/RMR.0000000000000105.
7
Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs).磁共振成像中的放大策略:传感造影剂(SCAs)的激活与积累。
J Magn Reson Imaging. 2006 Nov;24(5):971-82. doi: 10.1002/jmri.20724.
8
Novel live imaging techniques of cellular functions and in vivo tumors based on precise design of small molecule-based 'activatable' fluorescence probes.基于小分子“激活型”荧光探针的精确设计,实现细胞功能和活体肿瘤的新型活体成像技术。
Curr Opin Chem Biol. 2012 Dec;16(5-6):602-8. doi: 10.1016/j.cbpa.2012.10.023. Epub 2012 Nov 10.
9
Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide.一种新型不可逆响应型检测一氧化氮的PARACEST磁共振成像造影剂的设计与表征
Magn Reson Med. 2007 Dec;58(6):1249-56. doi: 10.1002/mrm.21428.
10
Theranostics: combining imaging and therapy.治疗诊断学:结合影像学与治疗。
Bioconjug Chem. 2011 Oct 19;22(10):1879-903. doi: 10.1021/bc200151q. Epub 2011 Aug 29.

引用本文的文献

1
Nanotechnology as a Versatile Tool for F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles.纳米技术作为功能磁共振成像(F-MRI)造影剂制剂的通用工具:透视全氟化合物和含氟化合物在纳米颗粒中的应用
Pharmaceutics. 2022 Feb 9;14(2):382. doi: 10.3390/pharmaceutics14020382.
2
7 Tesla and Beyond: Advanced Methods and Clinical Applications in Magnetic Resonance Imaging.7 特斯拉及更高场强:磁共振成像的高级方法和临床应用
Invest Radiol. 2021 Nov 1;56(11):705-725. doi: 10.1097/RLI.0000000000000820.
3
Computational pipeline for estimation of small-molecule T1 relaxation times.
小分子 T1 弛豫时间估算的计算流程。
J Magn Reson. 2020 May;314:106733. doi: 10.1016/j.jmr.2020.106733. Epub 2020 Apr 18.
4
Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics.精准医学中利用较少的 G 蛋白偶联受体:分子成像和治疗诊断的靶点。
Molecules. 2018 Dec 23;24(1):49. doi: 10.3390/molecules24010049.
5
Paradigms in Fluorescence Molecular Imaging: Maximizing Measurement of Biological Changes in Disease, Therapeutic Efficacy, and Toxicology/Safety.荧光分子成像中的范例:最大化疾病、治疗效果和毒理学/安全性中的生物学变化的测量。
Mol Imaging Biol. 2019 Aug;21(4):599-611. doi: 10.1007/s11307-018-1273-0.
6
A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.一种用于肝细胞癌的 GPC3 特异性适体介导的磁共振探针。
Int J Nanomedicine. 2018 Aug 1;13:4433-4443. doi: 10.2147/IJN.S168268. eCollection 2018.
7
Characterization of tumor vascular permeability using natural dextrans and CEST MRI.使用天然葡聚糖和 CEST MRI 进行肿瘤血管通透性特征分析。
Magn Reson Med. 2018 Feb;79(2):1001-1009. doi: 10.1002/mrm.27014. Epub 2017 Nov 28.